Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
VERA
#1670
Vera Therapeutics, Inc. Class A Common Stock
43.450
0
USD
-2.05%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-2.05%
Changement Mensuel
+7.10%
Evolution sur 6 mois
+46.10%
Changement Annuel
+46.10%
Clôture Précédente
44.360
0
Open
43.450
0
Bid
Ask
Low
43.450
0
High
43.450
0
Volume
102
Marchés
Actions des Marchés US
Soins de Santé
VERA
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
63.75 M
63.77 M
63.82 M
63.89 M
71.36 M
—
Valuation ratios
Enterprise value
2.66 B
1.53 B
1.53 B
1.88 B
3.35 B
8.29 B
Price to earnings ratio
-15.38
-8.01
-6.58
-7.28
-10.87
-32.74
Price to sales ratio
601.64
354.32
518.04
806.96
7 992.14
9 671.46
Price to cash flow ratio
-17.37
-8.94
-7.62
-8.57
-13.49
-38.61
Price to book ratio
4.05
0.8
0.75
0.9
5.5
7.94
Enterprise value to EBITDA ratio
-16.29
-8.09
-6.57
-7.01
-10.65
-32.32
Profitability ratios
Return on assets %
-0.07
-0.08
-0.13
-0.16
-0.12
-0.5
Return on equity %
-0.08
-0.1
-0.16
-0.2
-0.15
-0.61
Return on invested capital %
-2 450.51
—
—
—
-5 768.91
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-4 069.38
-6 462.6
23.78 K
-23.19 K
18.73 K
12.86 K
EBITDA margin %
-3 964.81
-6 352.99
23.85 K
-23.05 K
18.8 K
13.24 K
Net margin %
-3 612.73
-5 841.13
22.71 K
-22.18 K
18.11 K
12.8 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
25.67
27.68
17.03
12.21
13.64
70.55
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
-0
0
-0
0
Solvency ratios
Debt to assets ratio
0.08
0.09
0.13
0.15
0.11
0.48
Debt to equity ratio
0.09
0.1
0.17
0.19
0.13
0.59
Long term debt to total assets ratio
0.08
0.08
0.13
0.14
0.1
0.46
Long term debt to total equity ratio
0.09
0.1
0.16
0.19
0.12
0.57
Per share metrics
Operating cash flow per share
-0.71
-0.85
-0.86
-0.97
-1.09
-3.77
EBIT per share
-0.86
-0.88
-1.26
-1.31
-1.47
-4.93
EBITDA per share
-0.86
-0.88
-1.26
-1.31
-1.47
-4.92
Total debt per share
0.99
0.86
1.22
1.21
1.2
4.48
Cash per share
11.58
9.26
8.73
7.79
11.12
36.91
Net current asset value per share
11.77
9.52
8.96
8.01
11.35
37.83
Tangible book value per share
10.43
8.4
7.34
6.25
9.21
31.2
Working capital per share
11.31
9.17
8.43
7.35
10.52
35.47
Book value per share
10.43
8.4
7.34
6.25
9.21
31.2
Nouvelles
Vera Therapeutics nomme Jane Wright-Mitchell directrice juridique
Wolfe Research relève sa recommandation sur Vera Therapeutics en raison de la valorisation
Wolfe Research upgrades Vera Therapeutics stock rating on valuation
BofA Securities réitère sa recommandation d’achat sur Vera Therapeutics
Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities
Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Vera Therapeutics nomme Christopher Hite à son conseil d’administration
Vera Therapeutics adds Christopher Hite to board of directors
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com
Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)
VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg
Vera Therapeutics promeut Matt Skelton au poste de directeur commercial